title: Immuno-chemotherapy with a combination of rituximab, methotrexate, pirarubicin and procarbazine for patients with primary CNS lymphoma--a preliminary report.
authors.forename: Ryuya
authors.initials: R
authors.lastname: Yamanaka
authors.forename: Junpei
authors.initials: J
authors.lastname: Homma
authors.forename: Masakazu
authors.initials: M
authors.lastname: Sano
authors.forename: Naoto
authors.initials: N
authors.lastname: Tsuchiya
authors.forename: Naoki
authors.initials: N
authors.lastname: Yajima
authors.forename: Yoshikatsu
authors.initials: Y
authors.lastname: Shinbo
authors.forename: Akira
authors.initials: A
authors.lastname: Hasegawa
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Onda
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Tanaka
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016543:Central Nervous System Neoplasms / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D003131:Combined Modality Therapy / Q000379:methods*; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008223:Lymphoma / Q000188:drug therapy / Q000401:mortality / Q000628:therapy*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D010865:Pilot Projects; D011344:Procarbazine / Q000008:administration & dosage; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D011344:Procarbazine; D000069283:Rituximab; D004317:Doxorubicin; C027260:pirarubicin; D008727:Methotrexate